Back to today’s briefing

Story perspectives

Diabetes Drugs Could Slash Alzheimer's Risk, Study Finds

4/8/2025

34 5

Summary

Story summary

A groundbreaking study involving over 21 million patients reveals that diabetes medications, GLP-1 receptor agonists and SGLT2 inhibitors, may significantly lower the risk of Alzheimer’s disease and related dementias. This exciting discovery opens the door for further exploration into how these drugs could protect brain health and combat dementia.

1 of 1

Story summary

A groundbreaking study involving over 21 million patients reveals that diabetes medications, GLP-1 receptor agonists and SGLT2 inhibitors, may significantly lower the risk of Alzheimer’s disease and related dementias. This exciting discovery opens the door for further exploration into how these drugs could protect brain health and combat dementia.